You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

List of Excipients in API eltrombopag olamine

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing eltrombopag olamine

Subscribe to access the full database, or Get Started Free
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Novartis Pharmaceuticals Corporation	PROMACTA	eltrombopag olamine	0078-0684	CELLULOSE, MICROCRYSTALLINE
Novartis Pharmaceuticals Corporation	PROMACTA	eltrombopag olamine	0078-0684	FERRIC OXIDE RED
Novartis Pharmaceuticals Corporation	PROMACTA	eltrombopag olamine	0078-0684	FERROSOFERRIC OXIDE
Novartis Pharmaceuticals Corporation	PROMACTA	eltrombopag olamine	0078-0684	HYPROMELLOSES
Novartis Pharmaceuticals Corporation	PROMACTA	eltrombopag olamine	0078-0684	MAGNESIUM STEARATE
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Excipients in ANDA-approved (generic) drugs containing eltrombopag olamine

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC	Excipient
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300	MANNITOL
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300	SUCRALOSE
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300	XANTHAN GUM
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for eltrombopag olamine

Excipient focus: CELLULOSE, MICROCRYSTALLINE

eltrombopag olamine drug variants containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing CELLULOSE, MICROCRYSTALLINE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: FERRIC OXIDE RED

eltrombopag olamine drug variants containing FERRIC OXIDE RED

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing FERRIC OXIDE RED

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: FERROSOFERRIC OXIDE

eltrombopag olamine drug variants containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing FERROSOFERRIC OXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: HYPROMELLOSES

eltrombopag olamine drug variants containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing HYPROMELLOSES

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: MAGNESIUM STEARATE

eltrombopag olamine drug variants containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing MAGNESIUM STEARATE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: MANNITOL

eltrombopag olamine drug variants containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing MANNITOL

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: POLYETHYLENE GLYCOL 400

eltrombopag olamine drug variants containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing POLYETHYLENE GLYCOL 400

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: POVIDONE

eltrombopag olamine drug variants containing POVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing POVIDONE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

eltrombopag olamine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: SUCRALOSE

eltrombopag olamine drug variants containing SUCRALOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing SUCRALOSE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

Excipient focus: TITANIUM DIOXIDE

eltrombopag olamine drug variants containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing TITANIUM DIOXIDE

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

Excipient focus: XANTHAN GUM

eltrombopag olamine drug variants containing XANTHAN GUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Camber Pharmaceuticals Inc	eltrombopag olamine	31722-300
>Company	>Ingredient	>NDC

eltrombopag olamine drug variants not containing XANTHAN GUM

Subscribe to access the full database, or Get Started Free
Company	Ingredient	NDC
Novartis Pharmaceuticals Corporation	eltrombopag olamine	0078-0684
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.